PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) announced that CEO Brent Pfeiffenberger, Pharm.D., will deliver a company presentation at the H.C. Wainwright 27th Annual Global Investment Conference. The event takes place September 9-10, 2025, in New York, NY, where members of Century’s management team will also meet with investors.
An on-demand webcast of the presentation will be available beginning September 5, 2025, and remain accessible on the company’s website for at least 30 days.
Century Therapeutics is a clinical-stage biotechnology company specializing in developing iPSC-derived cell therapies for autoimmune diseases and cancers. Leveraging advances in cellular reprogramming, genetic engineering, and manufacturing, the company aims to create off-the-shelf therapies designed to improve patient access and outcomes.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.